Company News
- [Media Focus] Facility stability and readiness: Optimized design to ensure equivalency and speed in global biopharmaceutical manufacturing
- [Press Releases] Samsung Biologics completes spin-off to strengthen its focus as a pure-play CDMO
- [News Brief] Samsung Biologics to engage with global pharma at BIO-Europe and World ADC
- [Press Releases] Samsung Biologics reports third quarter 2025 financial results